CClinicalTrials.gg
RecruitingNCT06967909Updated Sep 10, 2026

Tai Chi and Acupuncture on Migraine Attack Prevention and Brain White Matter Changes

An interventional study of Tai Chi training and Acupuncture in Migraine and Migraine Disorder, sponsored by The Hong Kong Polytechnic University. Recruiting at 1 site in Hong Kong. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-10.

Sponsored by The Hong Kong Polytechnic University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Jan 2025, registered May 2025).
  • Started Jan 2025; still recruiting 1 year 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
132
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

The goal of this clinical trial is to determine the effectiveness of Tai Chi training and acupuncture on the migraine attacks and structural brain changes in women with episodic migraine.

Researchers will compare Tai Chi training to acupuncture treatment in a randomized controlled trial with 132 female participants. Participants will:

  • Be randomly assigned to either the Tai Chi group or the acupuncture group.
  • Undergo a 24-week intervention, with structured sessions for Tai Chi or scheduled acupuncture treatments.
  • Complete assessments through migraine diaries, questionnaires, physical measurements, MRI and TCD scans at various time points.

The study ensures participant safety through close monitoring, with medical support available in case of discomfort. Data confidentiality will be maintained, with encrypted storage and restricted access for research purposes.

Read the detailed description

The goal of this clinical trial is to determine whether Tai Chi training has the similar effectiveness in reducing the frequency of migraine attacks as acupuncture; and whether both Tai Chi and acupuncture can improve structural brain changes in women with episodic migraine. It also aims to examine whether the improvements in migraine features are linked to the structural brain changes and better cerebrovascular function after the intervention.

This study is a randomized controlled trial with 132 women who have episodic migraines. Participants will be randomly assigned to either the Tai Chi training group or the acupuncture treatment group, with 66 individuals in each group.

Participants will:

  • receive a 24-week intervention, which the Tai Chi group attends instructor-led training sessions and self-practice sessions, and the acupuncture group receives 30 treatment sessions over the same period.
  • Undergo assessments, including migraine diaries for migraine features and symptoms; migraine characteristics, lifestyle factors, body measurements (e.g., height, weight, and body composition), and advanced imaging techniques including MRI and TCD scans.
  • Data will be collected at baseline, the 12th week, and the 24th week. MRI will be used to assess white matter changes, while TCD will be used to evaluate cerebrovascular function. Both procedures are safe and non-invasive, with specific pre-exam precautions.

To ensure participant safety, Tai Chi sessions will be closely monitored for any adverse effects such as dizziness or falls, while acupuncture treatments will be supervised to address any discomfort. If participants experience intolerable migraines, they will receive guided medication management.

Confidentiality will be strictly maintained, with encrypted data storage and restricted access for research auditing. Personal identifiers will not be linked to the data, and all records will be securely stored for five years before being destroyed.

02

Conditions studied

  • Migraine
  • Migraine Disorder

Browse trials for

Keywords

  • Migraine
  • Tai Chi
  • Acupuncture
  • Women
  • Prophylaxis
03

In context

Migraine Disorders

1,528 studies on the registry are indexed under Migraine Disorders; 299 are open to participants now.

This study's planned enrollment of 132 is above the median of 80 across 1,175 interventional studies indexed under Migraine Disorders.

Browse Migraine Disorders studies →

Lead sponsor

The Hong Kong Polytechnic University is the lead sponsor of 659 studies on the registry; 250 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Chinese women aged 18 years and above;
  • Diagnosed with episodic migraines, with or without aura, according to the International Classification of Headache Disorders, 3rd edition (ICHD-3);
  • Migraine attack frequency ranging from 2 to 14 days per month (≥15 days/month is classified as chronic migraine and is not included in this study);
  • Assessed by a sports specialist as capable of engaging in moderate physical activity;
  • Residing in Hong Kong.

Exclusion criteria

Exclusion Criteria:

  • Unable to engage in moderate physical activity;
  • Comorbid with other neurological disorders;
  • Experiencing non-migraine headaches for more than 5 days per month;
  • Previous practice of Tai Chi or other mind-body exercises (such as yoga, biofeedback, meditation, etc.);
  • Received alternative treatments for migraines (such as acupuncture or Chinese medicine) during the recruitment period or within the past 12 weeks;
  • Undergoing preventive medication treatment for migraines during the recruitment period or within the past 12 weeks;
  • Excessive use of medication, taking antipsychotic or antidepressant drugs, or using analgesics for other chronic pain conditions for more than 3 days per month within the past 12 weeks;
  • Diagnosed with epilepsy or having a mental illness;
  • Pregnant, breastfeeding, or currently taking contraceptive medication.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
132 participants (estimated)

Study arms

  • Experimental
    Tai Chi training

    Participants in this arm will receive 24-week Tai Chi training.

    Behavioral: Tai Chi training

  • Active comparator
    Acupuncture

    Participants in this arm will receive 30 sessions of acupuncture treatment over a period of 24 weeks.

    Procedure: Acupuncture

Interventions

  • BehavioralTai Chi training

    Participants will receive 24 weeks of Tai Chi training. For the first 12 weeks, they will receive 3 instructor-led Tai Chi training sessions per week, and practice 2 Tai Chi sessions by themselves. In the next 12 weeks, they will receive 1 instructor-led Tai Chi session and self-practice 2 Tai Chi sessions per week. A modified 33-short form Yang-style Tai Chi Chuan will be adopted. The Tai Chi sessions will be operated by qualified instructors. Each 1-hour training session consists of 10 minutes brief warm-up stretching session followed by 45 minutes standard Tai Chi routine activities, and 5 minutes of cool-down stretching. The Tai Chi instructors are required to attend a training session that ensure all of them to deliver the same intervention protocol throughout the study. The research assistant will monitor the fidelity of intervention by visiting the Tai Chi sessions frequently. The training session will be delivered in group. The group size is 25-30 persons.

  • ProcedureAcupuncture

    Participants in the acupuncture group will receive 30 acupuncture treatment sessions, each last for 1 hour. Acupuncture will be performed every 2 days within one week, followed by a 3-day break, i.e., twice a week for the first 12 weeks; then it will be performed once every two weeks for the next 12 weeks. In total 30 sessions during 24 weeks treatment period. All acupuncture sessions will be administered by registered Traditional Chinese Medicine practitioners in Hong Kong with at least three years of clinical experience.

06

What researchers measure

Primary outcomes

  1. The difference in frequency of migraine attacks

    The frequency of migraine attacks will be measured by the number of attacks per month.

    Time frame: Between 4 weeks before randomization and weeks 9-12 / 21-24 after randomization

  2. The difference in migraine days

    The frequency of migraine days will be measured by the days with migraine attacks per month.

    Time frame: Between 4 weeks before randomization and weeks 9-12 / 21-24 after randomization

  3. The difference of white matter abnormalities (WMAs)

    All the participants in the Tai Chi group will be measured with MRI. The appearance, number, size and location of WMAs will be recorded. Two experienced neurologists or neuroradiologists will be invited to review the MRI scans independently. Scheltens' visual rating scale will be used to measure the degree of WMAs. Briefly, WMAs will be separately graded in each of the following locations: frontal lobes, temporal lobes, parietal lobes and occipital lobes. WMAs will be graded as follows: 0 (no lesions), 1 (hyperintensity \< 3 mm and n ≤ 5), 2 (\< 3 mm and n ≥ 6), 3 (4-10 mm and n ≤ 5), 4 (4-10 mm and n ≥ 6), 5 (≥ 11 mm and n ≥ 1), and 6 (confluent). The sum of scores from each location will be considered as the final score. Only the women who are identified WMAs (Scheltens' visual rating scores \>0) will take the MRI test again at the 24th week.

    Time frame: From the baseline to 24 weeks

Secondary outcomes

  1. The proportion of responders

    Defined as the proportion of patients with at least a 50% reduction of the number of attacks per month.

    Time frame: From the baseline to 12 weeks and 24 weeks

  2. The intensity of the headache

    The intensity of the headache measured by a Visual Analogue Scale (VAS). This scale is most commonly anchored by "no pain" (score of 0) and "worst imaginable pain" (score of 10). Higher scores indicate higher level of headache intensity.

    Time frame: From the baseline to 12 weeks and 24 weeks

  3. The duration of headache

    The duration of headache recorded in the migraine diary to the nearest 0.1 hour.

    Time frame: From the baseline to 12 weeks and 24 weeks

  4. Migraine related disability

    Migraine related disability measured by the Migraine Disability Assessment Score (MIDAS). The MIDAS consists of five items that reflect the number of days reported as either missing or with reduced productivity at work, home, and social events in last 3 months and two additional items that assess the number of days with headaches in the last 3 months and a scale of the painfulness of the headaches. The MIDAS is scored as the sum of days reported in the first five questions. Higher scores are indicative of more disability.

    Time frame: From the baseline to 12 weeks and 24 weeks

  5. Stress level

    Stress level evaluated by the Perceived Stress Scale-14 (PSS-14). The total score of PSS-14 ranges from 0 to 56 with higher scores indicating higher perceived stress.

    Time frame: From the baseline to 12 weeks and 24 weeks

  6. Sleep quality

    Sleep quality examined by the Chinese version of the Pittsburgh Sleep Quality Index (PSQI). The global score of PSQI ranges from 0 to 21 with a higher score indicating worse sleep quality.

    Time frame: From the baseline to 12 weeks and 24 weeks

  7. Fatigue level

    Fatigue level evaluated by the Numeric Rating Scale-fatigue scale (NRS). NRS evaluates fatigue level at a 0-to-10 scale, with 0 indicating no fatigue and 10 indicating the worst possible fatigue.

    Time frame: From the baseline to 12 weeks and 24 weeks

  8. Health related Quality-of-Life

    Health related Quality-of-Life measured by the Migraine-Specific Quality-of-Life Questionnaire (MSQ). The total scores of MSQ range from 0-100, with a higher score indicating better Quality-of-Life.

    Time frame: From the baseline to 12 weeks and 24 weeks

  9. Weight

    Weight in kilograms

    Time frame: From the baseline to 12 weeks and 24 weeks

  10. Height

    Height in meters

    Time frame: From the baseline to 12 weeks and 24 weeks

  11. Waist circumference

    Waist circumference in centimeter

    Time frame: From the baseline to 12 weeks and 24 weeks

  12. Hip circumference

    Hip circumference in centimeter

    Time frame: From the baseline to 12 weeks and 24 weeks

  13. Percent body fat

    Percent body fat in %

    Time frame: From the baseline to 12 weeks and 24 weeks

  14. The difference of pulsatility index (PI)

    PI in neck vessels will be measured and recorded by Transcranial Doppler (TCD).

    Time frame: From the baseline to 12 weeks and 24 weeks

  15. The difference of mean blood flow velocity (MBFV)

    MBFV in neck vessels will be measured and recorded by Transcranial Doppler (TCD).

    Time frame: From the baseline to 12 weeks and 24 weeks

  16. The difference of impaired cerebrovascular responsiveness (CVR)

    CVR in neck vessels will be measured and recorded by Transcranial Doppler (TCD).

    Time frame: From the baseline to 12 weeks and 24 weeks

07

Study locations

1 of 1 sites recruiting
  • The Hong Kong Polytechnic University
    Hung Hom, Hong Kong, Hong Kong
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06967909
Lead sponsor
The Hong Kong Polytechnic University
Responsible party
XIE Yao Jie Grace (Associate Professor, The Hong Kong Polytechnic University) — Principal investigator
First posted
May 13, 2025
Start date
Jan 1, 2025
Primary completion
Oct 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Sep 10, 2026

Study contacts

Yao Jie Xie, PhD
Contact
grace.yj.xie@polyu.edu.hk
(852) 3400 3798
Yao Jie Xie, PhD
principal investigator · The Hong Kong Polytechnic University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion